Detalle Publicación

Monitoring of everolilmus trough concentrations for achieving optimal tolerance in the management of tuberous sclerosis complex

Título de la revista: PEDIATRIC NEUROLOGY
ISSN: 0887-8994
Volumen: 51
Número: 3
Páginas: e9-e10
Fecha de publicación: 2014
Resumen:
Currently there is no strong evidence to recommend any determined trough plasma levels, and thus we wait for additional observations and clinical trials to clarify the optimal dosage required to avoid unnecessary side effects. Meanwhile, we have found a safe and acceptable response with plasma levels within the lower range of efficacy described.
Impacto: